Stroke

Statins, CCBs Confer Long-Term Mortality Benefit in Hypertension

Statins, CCBs Confer Long-Term Mortality Benefit in Hypertension

By

Mortality benefits from atorvastatin- and amlodipine-based antihypertensive treatments extend beyond 10 years of treatment.

Psychological Distress Linked to Increased Risk of MI, Stroke

Psychological Distress Linked to Increased Risk of MI, Stroke

Psychological distress had a dose-dependent, positive association with myocardial infarction and stroke in men and women.

In Stroke Survivors, Cost-Related Nonadherence Down After ACA

In Stroke Survivors, Cost-Related Nonadherence Down After ACA

Among adult survivors of stroke, Medicaid costs increased while nonadherence costs decreased after Affordable Care Act implementation.

The Role of Public Education Campaigns in Increasing Patient Response to TIA and Minor Stroke

The Role of Public Education Campaigns in Increasing Patient Response to TIA and Minor Stroke

By

The UK FAST campaign attempted to bolster patient response to both transient ischemic attack and minor stroke.

Locally Asymptomatic Ischemic Stroke May Present as Migraine Aura

Locally Asymptomatic Ischemic Stroke May Present as Migraine Aura

By

Local ischemia after an acute ischemic stroke may trigger a widely migrating cortical wave of spreading depolarization, which may present as migraine aura.

Breastfeeding Linked to Lower Risk of Stroke After Menopause

Breastfeeding Linked to Lower Risk of Stroke After Menopause

Stroke risk 19% lower with breastfeeding for 1 to 6 months, and there was a stronger link for longer duration.

CHEST Releases Guideline for Antithrombotic Therapy in Atrial Fibrillation

CHEST Releases Guideline for Antithrombotic Therapy in Atrial Fibrillation

By

Patients with atrial fibrillation who have ≥1 non-sex CHA2DS2VASc stroke risk factor should receive oral anticoagulation as antithrombotic therapy.

Alteplase unlikely to reduce disability after mild stroke without disabling deficits

In this randomized controlled trial, administration of alteplase within 3 hours of mild stoke did not lead to a reduction in disability at 90 days following stroke compared with aspirin.

Quality improvement interventions increase adherence to performance measures for stroke in China

In this cluster-randomized clinical trial, quality improvement interventions led to slightly greater adherence of evidence-based, performance measures compared with usual care for acute ischemic stroke management in China.

Concomitant NSAID and Anticoagulant Use May Increase Stroke, Bleeding Risk in Afib

Concomitant NSAID and Anticoagulant Use May Increase Stroke, Bleeding Risk in Afib

By

Patients with atrial fibrillation who take NSAIDs in addition to oral anticoagulants may have an increased risk for major bleeding and stroke.

Ultra-Early Neurological Deterioration Common in Stroke

Ultra-Early Neurological Deterioration Common in Stroke

Ultra-early neurological deterioration was seen most often in patients with intracranial hemorrhage patients and tied to worse 3-month outcomes.

Apixaban Lowers Bleeding Risk in Afib With End-Stage Kidney Disease

Apixaban Lowers Bleeding Risk in Afib With End-Stage Kidney Disease

By

Apixaban demonstrated superiority over warfarin in terms of reducing the risk for major bleeding in patients with atrial fibrillation and end-stage kidney disease who were on dialysis.

PFO Closure Plus Antiplatelet Therapy Advised for Cryptogenic Stroke

PFO Closure Plus Antiplatelet Therapy Advised for Cryptogenic Stroke

PFO closure plus antiplatelets recommended over antiplatelet therapy alone for patients younger than 60 years.

Unraveling the Relationship Between COPD and Stroke

Unraveling the Relationship Between COPD and Stroke

By

Although COPD has been identified as a risk factor for cardiovascular disease, researchers are less certain about the relationship between COPD and stroke.

Factors Increasing Risk for Hemorrhagic Stroke After Infective Endocarditis

Factors Increasing Risk for Hemorrhagic Stroke After Infective Endocarditis

By

The apparent increase in risk for hemorrhagic stroke among patients with previous infective endocarditis was explained by the mediating factors of mechanical heart valve insertion, atrial fibrillation, and anticoagulation medication.

WTC-Related PTSD May Up Risk for Stroke, MI in Clean-Up Crew

WTC-Related PTSD May Up Risk for Stroke, MI in Clean-Up Crew

There was a similar magnitude of risk in men and women, independent of depression.

Stroke Rates Lower After PCI vs CABG at 5 Years

Stroke Rates Lower After PCI vs CABG at 5 Years

Stroke risk remained significantly lower after PCI than after CABG at 5-year follow-up.

Apixaban Is Safest Direct Oral Anticoagulant vs Warfarin

Apixaban Is Safest Direct Oral Anticoagulant vs Warfarin

Apixaban reduced risks of major, intracranial, and gastrointestinal bleeding compared with warfarin.

Transfeminine Persons Have Increased VTE Incidence

Transfeminine Persons Have Increased VTE Incidence

More pronounced differences in venous thromboembolism and ischemic stroke in individuals who initiated hormone treatment during follow-up.

High-Risk <i>APOL1</i> Not Tied to CHD, Stroke in Postmenopausal Black Women

High-Risk APOL1 Not Tied to CHD, Stroke in Postmenopausal Black Women

High-risk APOL1 genotype was linked to HFpEF hospitalization in postmenopausal black women.

Marriage May Protect Against Cardiovascular Disease

Marriage May Protect Against Cardiovascular Disease

An association was seen between marital status and risk and prognosis of coronary heart disease or stroke.

Half of Cardiovascular Events Occur Between 2 to 5 Years After Stroke

Half of Cardiovascular Events Occur Between 2 to 5 Years After Stroke

The rate of a composite of stroke, acute coronary syndrome, or death from cardiovascular causes occurred in 12.9% of patients; 50.1% of events occurring in the second to fifth years.

Ischemic Stroke Risk Increased With Higher Platelet Reactivity Post-DES Implantation

Ischemic Stroke Risk Increased With Higher Platelet Reactivity Post-DES Implantation

High platelet reactivity was associated with an increased risk for ischemic stroke in patients who had undergone drug-eluting stent implantation.

Rivaroxaban Use in Older Patients: Does Age Influence Safety, Efficacy?

Rivaroxaban Use in Older Patients: Does Age Influence Safety, Efficacy?

By

Data from large Phase 3 studies showed that treatment with rivaroxaban was found to be safe and effective in older patients.

Patient With COPD, Smoking History Presents to ED With Sensory Loss

Patient With COPD, Smoking History Presents to ED With Sensory Loss

By

A 72-year-old man with a 50 pack-year smoking history and multiple comorbidities, including COPD, presents to the emergency department with left-sided hemiparesis and sensory loss.

New Coagulation Monitoring Device Allows for Wireless Reporting of INR Results

New Coagulation Monitoring Device Allows for Wireless Reporting of INR Results

By

The system is intended for properly selected trained users ≥22 years of age who have been stabilized on anticoagulation with vitamin K antagonists for ≥6 weeks.

Disparities for Recurrent Hemorrhagic Stroke Risk Unexplained

Disparities for Recurrent Hemorrhagic Stroke Risk Unexplained

Higher risk for second hemorrhagic stroke in blacks and Hispanics is not fully explained by hypertension severity.

Under New Guidelines, More Stroke Survivors With Hypertension Diagnosis

Under New Guidelines, More Stroke Survivors With Hypertension Diagnosis

More stroke survivors are not within the new recommended blood pressure targets compared with Joint National Committee report.

Stroke Risk Highest in Paroxysmal Afib With Greater Burden of Afib

Stroke Risk Highest in Paroxysmal Afib With Greater Burden of Afib

By

A greater burden of atrial fibrillation or flutter in patients with paroxysmal atrial fibrillation was associated with a higher risk for stroke when not taking anticoagulants.

No Consistent Cardiovascular Benefit Seen for Supplements

No Consistent Cardiovascular Benefit Seen for Supplements

The evidence for preventive benefits, no effect, or elevated risk for all-cause mortality was generally moderate- or low-quality.

Sign Up for Free e-Newsletters